125 related articles for article (PubMed ID: 21082971)
1. New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia.
Martinelli G; Iacobucci I; Soverini S; Piccaluga PP; Cilloni D; Pane F
Expert Rev Hematol; 2009 Jun; 2(3):297-303. PubMed ID: 21082971
[TBL] [Abstract][Full Text] [Related]
2. New targets for Ph+ leukaemia therapy.
Martinelli G; Iacobucci I; Papayannidis C; Soverini S
Best Pract Res Clin Haematol; 2009 Sep; 22(3):445-54. PubMed ID: 19959093
[TBL] [Abstract][Full Text] [Related]
3. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
4. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; Foà R; Baccarani M; Martinelli G
Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
6. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
Mullighan CG
Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of high-risk acute lymphoblastic leukemia.
Collins-Underwood JR; Mullighan CG
Leukemia; 2010 Oct; 24(10):1676-85. PubMed ID: 20739952
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase gene expression profiling and in vitro functional experiments identify novel potential therapeutic targets in adult acute lymphoblastic leukemia.
Messina M; Chiaretti S; Tavolaro S; Peragine N; Vitale A; Elia L; Sica S; Levis A; Guarini A; Foà R
Cancer; 2010 Jul; 116(14):3426-37. PubMed ID: 20564080
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a new Philadelphia chromosome-positive acute lymphoblastic leukemia cell line (SK-9) with T315I mutation.
Okabe S; Tauchi T; Ohyashiki K
Exp Hematol; 2010 Sep; 38(9):765-72. PubMed ID: 20471447
[TBL] [Abstract][Full Text] [Related]
11. Genomic analysis of acute leukemia.
Mullighan CG
Int J Lab Hematol; 2009 Aug; 31(4):384-97. PubMed ID: 19486196
[TBL] [Abstract][Full Text] [Related]
12. Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation.
Håkansson P; Nilsson B; Andersson A; Lassen C; Gullberg U; Fioretos T
Genes Chromosomes Cancer; 2008 Apr; 47(4):267-75. PubMed ID: 18181176
[TBL] [Abstract][Full Text] [Related]
13. Building better therapy for children with acute lymphoblastic leukemia.
Carroll WL; Raetz EA
Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616
[TBL] [Abstract][Full Text] [Related]
14. Improving outcomes for high-risk ALL: translating new discoveries into clinical care.
Hunger SP; Raetz EA; Loh ML; Mullighan CG
Pediatr Blood Cancer; 2011 Jun; 56(6):984-93. PubMed ID: 21370430
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions.
Mullighan CG; Downing JR
Leukemia; 2009 Jul; 23(7):1209-18. PubMed ID: 19242497
[TBL] [Abstract][Full Text] [Related]
16. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
Haematologica; 2010 Oct; 95(10):1683-90. PubMed ID: 20534699
[TBL] [Abstract][Full Text] [Related]
17. Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).
Kawamura M; Taki T; Kaku H; Ohki K; Hayashi Y
Genes Chromosomes Cancer; 2015 Jul; 54(7):401-8. PubMed ID: 25951811
[TBL] [Abstract][Full Text] [Related]
18. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
19. How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia.
Roberts KG; Mullighan CG
Curr Opin Pediatr; 2011 Feb; 23(1):34-40. PubMed ID: 21169835
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations targeting lymphoid development in acute lymphoblastic leukemia.
Collins-Underwood JR; Mullighan CG
Curr Top Dev Biol; 2011; 94():171-96. PubMed ID: 21295687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]